AVEO Pharmaceuticals (AVEO) Posts Q4 Loss of 32c/Share; Med Chief Slichenmyer to Leave Co.
Tweet Send to a Friend
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q4 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
